Fluoride release process of (resin-modified) glass-ionomer cements versus (polyacid-modified) composite resins

Biomaterials
R M VerbeeckL M Trimpeneers

Abstract

The fluoride release of conventional and resin-modified glass-ionomers is reviewed and compared to that of fluoride-releasing (polyacid-modified) composite resins. Each formulation displays a typical fluoride release profile. The cumulative amount of fluoride released is described by [F]c = [F](I)t/(t + t1/2) + beta square root t for glass ionomers whether resin-modified or not, whereas for composite resins this quantity is given by [F]c = [F](I)t/(t + t1/2) + alpha t. Both equations indicate that two kinetic processes are responsible for the fluoride release profiles. The kinetic parameters [F](I), t1/2, beta and alpha depend on the formulation. On the basis of the exchange characteristics for fluoride, an attempt is made to explain the mechanisms responsible for these fluoride release processes.

Citations

Jun 5, 2007·Journal of Materials Science. Materials in Medicine·Beata CzarneckaJohn W Nicholson
Oct 9, 2007·Journal of Materials Science. Materials in Medicine·Reisha N Rafeek
Apr 26, 2008·Journal of Materials Science. Materials in Medicine·Elizabeta GjorgievskaSnezana Iljovska
Aug 11, 2004·Dental Materials : Official Publication of the Academy of Dental Materials·Hsiu-Ming HsuMing-Kuang Guo
Jul 20, 2005·Dental Materials : Official Publication of the Academy of Dental Materials·Raimond N B van DuinenAlbert J Feilzer
May 18, 2001·Dental Materials : Official Publication of the Academy of Dental Materials·C W VercruysseR M Verbeeck
Aug 15, 2002·Dental Materials : Official Publication of the Academy of Dental Materials·Roeland J G De Moor, Ronald M H Verbeeck
Jun 24, 1999·Dental Materials : Official Publication of the Academy of Dental Materials·R J De Moor, R M Verbeeck
Sep 14, 1999·Dental Materials : Official Publication of the Academy of Dental Materials·M A Cattani-LorenteJ M Meyer
Mar 5, 2003·Biomaterials·An M J C De WitteRonald M H Verbeeck
Jan 26, 2002·Journal of Dentistry·L BreschiG Mazzotti
Mar 5, 2003·Journal of Dentistry·G R CavesW H Gilmour
Aug 22, 2001·The Journal of Prosthetic Dentistry·M Helvatjoglu-AntoniadesH Kapetanios
Jul 9, 2014·Dental Materials : Official Publication of the Academy of Dental Materials·T De CaluwéR M H Verbeeck
Apr 1, 2003·European Journal of Oral Sciences·John F McCabeSharanbir K Sidhu
Aug 11, 2009·Dental Materials Journal·Nuran YanikoğluBaykal Yilmaz
Feb 12, 2004·International Endodontic Journal·M A A De Bruyne, R J G De Moor
Feb 27, 2008·International Journal of Paediatric Dentistry·Vasilis AhiropoulosYannis Papadogiannis
Apr 18, 2006·Dental Materials : Official Publication of the Academy of Dental Materials·Annette WiegandThomas Attin
Aug 10, 2005·Dental Materials : Official Publication of the Academy of Dental Materials·Wailan D ChanAmin S Rizkalla
Jan 13, 2015·Journal of Investigative and Clinical Dentistry·Maria Denise Rodrigues de MoraesLidiany Karla Azevedo Rodrigues
Nov 26, 2013·Materials Science & Engineering. C, Materials for Biological Applications·Liyuan ChengXiaoping Yang
Oct 1, 2007·Journal of Applied Oral Science : Revista FOB·Rosa Maria Viana de Bragança GarcezPaulo Amarante de Araújo
Jul 14, 1999·Journal of Dental Research·E A De MaeyerC W Vercruysse
Jul 5, 2001·Journal of Dental Research·C L DhondtR M Verbeeck
Oct 17, 2009·The Open Dentistry Journal·J L R ArrondoJ Ellacuria
Sep 22, 1999·Journal of Biomedical Materials Research·A C WanG W Hastings
Aug 11, 2006·Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine·J W Nicholson, B Czarnecka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.